PTGX Operating Income
Protagonist Therapeutics Inc · Operating Income
PTGX Operating Income
Latest reported$58.34Mperiod ending
PTGX TTM Operating Income (-$14.79M → $58.34M)
TTM operating income
High-resolution chart · PNG
PTGX operating income history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Income (USD) |
|---|---|
| 58,342,000 | |
| -142,465,000 | |
| -158,127,000 | |
| 19,008,000 | |
| 23,976,000 | |
| 27,224,000 | |
| 252,843,000 | |
| 149,112,000 | |
| 152,239,000 | |
| 148,678,000 | |
| -93,652,000 | |
| -153,217,000 | |
| -147,194,000 | |
| -146,283,000 | |
| -131,373,000 | |
| -132,773,000 | |
| -134,396,000 | |
| -123,835,000 | |
| -126,745,000 | |
| -107,659,000 | |
| -81,505,000 | |
| -68,840,000 | |
| -64,516,000 | |
| -62,985,000 | |
| -72,380,000 | |
| -85,570,000 | |
| -80,521,000 | |
| -78,634,000 | |
| -70,856,000 | |
| -48,688,000 | |
| -42,269,000 | |
| -30,370,000 | |
| -25,961,000 | |
| -31,853,000 | |
| -37,897,000 | |
| -45,781,000 | |
| -47,939,000 | |
| -39,899,000 | |
| -32,666,000 | |
| -26,270,000 | |
| -23,153,000 | |
| -19,145,000 | |
| -14,794,000 |